U.S. Biotech Stock News

Nuvalent (NasdaqGS:NUVL) filed a significant shelf registration, creating the option to raise fresh capital over time. The company also presented at a major healthcare conference, sharing updates on its oncology pipeline with investors and industry peers. For investors following biotech, these two moves highlight potential next steps for Nuvalent, a precision oncology company. Shelf capacity can be important in a sector where clinical programs, regulatory milestones and potential partnering...

Nordic American Tankers (NAT) is in the spotlight after a stronger fourth quarter, fresh earnings, and increased insider buying. Management is highlighting fleet upgrades, operational efficiencies, and an ongoing focus on regular dividends. See our latest analysis for Nordic American Tankers. The latest earnings beat, insider buying and stronger tanker rates have come alongside a sharp 66.8% year to date share price return and a very strong 150.5% one year total shareholder return. This...

FuboTV (NYSE:FUBO) plans to discontinue PayPal as a payment method for subscribers. From April 2, 2026, users will need to pay via direct debit or credit card. The change affects both existing subscribers and new sign ups on the platform. FuboTV operates a sports focused live TV streaming service that competes with both traditional pay TV and other over the top providers. Payment infrastructure is a key part of that model, affecting how easily subscribers can join, manage their accounts,...

KBRA’s auto loan ABS move puts fresh attention on OneMain Holdings (OMF) KBRA’s preliminary ratings on notes from OneMain Direct Auto Receivables Trust 2026-1, the company’s first 2026 auto loan ABS deal with a three year revolving period, are putting fresh focus on OneMain Holdings (OMF) today. See our latest analysis for OneMain Holdings. At a share price of US$53.41, OneMain’s 1 month share price return of 15.49% decline and year to date share price return of 22.67% decline contrast with...

If you are wondering whether First Bancorp's current share price reflects its true worth, you are not alone and that is exactly what this article will unpack. The stock trades at US$55.93, with a 7 day return of 1.5% decline, a 30 day return of 7.6% decline, and longer term returns of 9.9% year to date, 41.5% over 1 year, 56.4% over 3 years and 30.0% over 5 years that may have reshaped how investors view its potential and risk. Recent coverage of First Bancorp has focused on how investors...

Golar LNG (GLNG) has drawn fresh attention after reporting fourth quarter and full year 2025 results, alongside a declared cash dividend and the completion of a multi year share repurchase program. See our latest analysis for Golar LNG. The recent earnings release, dividend declaration and completion of the buyback program appear to be feeding into strong momentum, with a 30 day share price return of 16.02% and a 1 year total shareholder return of 47.85% supporting a much stronger multi year...

Ciena (CIEN) opened fiscal Q1 2026 with revenue of US$1.4b and basic EPS of US$1.06, putting a clear focus on how its income statement is scaling alongside earnings. The company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.4b in Q1 2026, while basic EPS shifted from US$0.31 to US$1.06 over the same period, set against trailing 12 month EPS of US$1.61. With net income and margins now playing a larger role in the story, this set of results points investors to profitability...

Recently, BioNTech highlighted its evolution from a COVID-19 vaccine leader into a broader biotech group focused on oncology, underscored by its acquisition of Chinese startup Biotheseus and a follow-on collaboration with Bristol Myers around antibody candidate BNT327 that includes upfront payments and future royalty sharing. An interesting implication is that BioNTech is now using targeted acquisitions as a platform to secure large-pharma partnerships, aiming to convert its oncology...

BGC Group (BGC) has been drawing attention after a recent move in its share price, with short term returns contrasting against its longer performance. This has prompted investors to reassess the brokerage and financial technology firm’s profile. See our latest analysis for BGC Group. At a latest share price of US$9.34, BGC Group’s recent 1 day and 7 day share price declines sit alongside a 30 day share price return of 3.9%, with multi year total shareholder returns above 90% indicating...

In early March 2026, Tango Therapeutics announced a clinical trial collaboration and supply agreement with Erasca to test Erasca’s pan-RAS molecular glue ERAS-0015 alongside Tango’s PRMT5 inhibitor vopimetostat in a Phase 1/2 study for MTAP-deleted pancreatic and RAS-mutant non-small cell lung cancers. This pairing targets a specific genetic vulnerability, MTAP deletion with co-occurring RAS mutations, offering a dual-mechanism approach that could help address resistance in these...

SS&C Technologies Holdings (SSNC) is back in focus after reporting an 8.1% year-on-year revenue increase, beating expectations and lifting full-year revenue and EPS guidance compared with earlier forecasts. See our latest analysis for SS&C Technologies Holdings. The latest results come after a mixed period for the stock, with a 2.84% 1 month share price return but a 14.19% 3 month share price decline and a 10.58% 1 year total shareholder return decline. However, the 3 year total shareholder...

Walmart (NasdaqGS:WMT) has agreed to pay US$100 million to settle a regulatory case tied to its Spark Driver delivery program. The settlement introduces new compliance obligations for Walmart's e-commerce and delivery operations. Separately, Walmart is rolling out digital shelf labels across its stores in a nationwide deployment. The digital shelf label rollout is aimed at updating in store pricing and inventory management processes. For you as an investor following Walmart, these two moves...

Recent analyst commentary around Insmed (INSM) has centered on updated Brinsupri guidance for fiscal 2026 of at least US$1b in sales, along with expectations for a larger U.S. addressable market. See our latest analysis for Insmed. Despite the recent Brinsupri headlines, Insmed’s share price has softened in the near term, with a 30-day share price return of 8.08% and a 90-day return of 31.31%. At the same time, the 1-year total shareholder return of 87.11% and the very large 3-year total...

Super Group (SGHC) announced an increase to its annual dividend program. The company declared its first higher quarterly dividend under the new policy. The move signals a shift in how NYSE:SGHC is approaching shareholder returns. For investors watching NYSE:SGHC, this updated dividend approach comes after a period of mixed share performance. The stock is trading at $10.64, with a 30 day return of 18.4% and a 1 year return of 58.7%, while year to date performance shows an 8.6% decline. Over...

What Brighthouse Financial’s Recent Returns Mean For Investors Without a single headline event driving attention, Brighthouse Financial (BHF) has still caught investors’ eyes after a recent period of mixed share performance and solid reported revenue and net income figures. See our latest analysis for Brighthouse Financial. The recent 1 month share price return of 7.3% decline and 90 day share price return of 9.4% decline contrast with a 1 year total shareholder return of 9.2%. This suggests...

Tyson Foods and the University of Arkansas have agreed to a new jersey patch sponsorship for Razorback athletics, one of the early deals of its kind in college sports. The expanded partnership increases Tyson’s visibility across the university’s athletic programs and facilities. At the same time, U.S. lawmakers are renewing scrutiny of meat industry concentration, with Tyson Foods cited in discussions tied to elevated beef prices. Proposed legislation targets consolidation across the sector,...

Oracle, NYSE:ORCL, is planning major workforce reductions affecting thousands of roles across multiple divisions. The company is reallocating capital to expand AI focused data centers to support clients such as OpenAI, xAI, and Meta. Oracle and OpenAI have canceled a planned flagship AI data center project in Texas, with resources reportedly redirected to existing infrastructure. Oracle enters these changes with its shares at $152.96 and a mixed return profile, including 5.2% over the past...

Why Lear Stock Is Back On Investors’ Radar Lear (LEA) has drawn fresh attention after recent trading left the shares with mixed short term performance but a stronger past year, prompting investors to reassess how the auto supplier’s fundamentals line up with current pricing. See our latest analysis for Lear. After a softer patch that includes a 1 day share price return of 1.47% and a 7 day share price return of 8.43%, Lear still sits at US$120.18, with a 1 year total shareholder return of...

Micron Technology (NasdaqGS:MU) has introduced a 256GB SOCAMM2 LPDRAM module for AI data centers, described as an industry leading step in memory capacity and energy efficiency. The company has started shipping samples of the 256GB module to customers for AI and data center workloads. Micron is set to join the S&P 100 index, reflecting its growing presence among large US listed companies. Micron Technology, known for DRAM, NAND and other memory products used in data centers, PCs and...

FIGS (NYSE:FIGS) recently highlighted accelerated international growth across key markets. The company reported strong operational performance alongside new consumer campaigns, including a program honoring women in healthcare. FIGS expanded its retail footprint with additional physical stores and pushed further into non scrub product lines. FIGS, known for its premium medical apparel, sits at the intersection of healthcare, retail, and lifestyle branding. As more healthcare professionals...

Guidewire Software Q2 2026 Earnings Snapshot Guidewire Software (GWRE) has put up another solid print for Q2 2026, with revenue at US$359.1 million and basic EPS of US$0.71, setting the tone for a cleaner run of profitability. The company has seen revenue move from US$289.5 million and basic EPS of US$0.45 loss in Q2 2025 to US$359.1 million and US$0.71 EPS in Q2 2026, while trailing 12 month EPS sits at US$2.24 on revenue of about US$1.3 billion, giving investors more visibility on earnings...

If you are wondering whether National Energy Services Reunited is still attractively priced after its recent run, you are not alone. This article is here to unpack the valuation story in a clear, practical way. The share price last closed at US$20.86, with a 1 year return of 163.4%, a 3 year return of 254.2%, and a year to date return of 32.1%. The stock has seen a 16.7% decline over the past 7 days and a 2.0% return over the past 30 days. Recent news flow around National Energy Services...

Illumina stock after recent performance Illumina (ILMN) has drawn fresh attention after a period where the share price has declined about 7% over the past month and roughly 3% over the past 3 months, despite a positive 1 year total return. See our latest analysis for Illumina. Short term momentum has faded for Illumina, with a 1 day share price decline of 2.82% and softer recent returns, even though the 1 year total shareholder return sits at 43.87%. If Illumina’s recent swings have you...

The FDA’s decision to lift the clinical hold on Intellia Therapeutics (NTLA) MAGNITUDE Phase 3 trial and the new hereditary angioedema data for lonvoguran ziclumeran have refocused attention on the company’s gene editing pipeline. See our latest analysis for Intellia Therapeutics. At a share price of $13.44, Intellia has seen a 39.85% 90 day share price return and a 45.93% year to date share price return. The 5 year total shareholder return of 79.49% and 3 year total shareholder return of...